Acorda Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)·PEARL RIVER, NY

Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York.

CEO

Cohen Ron

Summary Financials

Revenue

$118.6M

-8.1% YoY

FY 2023

Adj. EBITDA

-$2.5M

-2.1% margin

FY 2023

Net Income

-$65.9M

-55.6% margin

FY 2023

EPS (Diluted)

-$65.23

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$45.6M

FY 2023

Total Debt

$1.1M

FY 2013

Net Cash

$44.5M

FY 2013

Enterprise Value

—

Debt / EBITDA

17.6x

FY 2023

EV / EBITDA

—

Employees

—

Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York.

CEO

Cohen Ron

Revenue

$118.6M

-8.1% YoY

FY 2023

Adj. EBITDA

-$2.5M

-2.1% margin

FY 2023

Net Income

-$65.9M

-55.6% margin

FY 2023

EPS (Diluted)

-$65.23

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$45.6M

FY 2023

Total Debt

$1.1M

FY 2013

Net Cash

$44.5M

FY 2013

Enterprise Value

—

Debt / EBITDA

17.6x

FY 2023

EV / EBITDA

—

Employees

—